The U.S. Food and Drug Administration has approved Lynkuet, a new medication that does not contain hormones to treat hot ...
Elinzanetant belongs to a new class of drugs designed to target what is believed to be a key mechanism responsible for ...
The U.S. Food and Drug Administration approved Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and ...
Under pressure from the administration of President Donald Trump, Michigan Medicine, the University of Michigan's medical center, will stop providing gender-affirming care ― hormone therapy or puberty ...